Related Experiment Video
Updated: Jun 1, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Downregulated expression of inhibitor of growth 4 (ING4) in advanced colorectal cancers: a non-randomized
Qi You1, Xi-Shan Wang, Song-Bin Fu
1Department of Colorectal Surgery, The Tumor Hospital of Harbin Medical University, Harbin, People's Republic of China.
Abstract:
Colorectal cancer has a high cure rate if it can be detected early. Identifying and understanding the genes involved may enable early diagnosis and reduce mortality. The aim of our study was to investigate the correlation between the expression of ING4 and the pathological features in patients with colorectal cancer. We assayed ING4 protein expression levels in tumor samples from 97 patients diagnosed with colorectal cancer between January 2001 and January 2002. The patients received no other treatments except surgery. ING4 protein expression was downregulated in adenoma relative to normal mucosa and further reduced in colorectal cancer tissues. Furthermore, the suppression of ING4 expression was also related to the more advanced Dukes' stages. We observed that ING4 expression levels in patients with lymphatic metastasis were lower than those without metastasis. Together, our results indicate that ING4 play a role in colorectal carcinoma progression.
Insights
Early detection of colorectal cancer improves outcomes. Our study found that ING4 gene expression is reduced in colorectal tumors and linked to advanced disease stages and metastasis, suggesting its role in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) has a high cure rate when detected early.
- Identifying genes involved in CRC can aid early diagnosis and reduce mortality.
- The role of ING4 in colorectal carcinoma progression requires further investigation.
Purpose of the Study:
- To investigate the correlation between ING4 gene expression and pathological features in colorectal cancer patients.
- To assess the potential of ING4 as a biomarker for colorectal cancer diagnosis and prognosis.
Main Methods:
- Assayed ING4 protein expression levels in tumor samples from 97 colorectal cancer patients.
- Analyzed ING4 expression in relation to adenoma, normal mucosa, and colorectal cancer tissues.
- Correlated ING4 expression with Dukes' stages and lymphatic metastasis.
Main Results:
- ING4 protein expression was downregulated in adenoma compared to normal mucosa.
- ING4 expression was further reduced in colorectal cancer tissues.
- Suppressed ING4 expression correlated with advanced Dukes' stages and lymphatic metastasis.
Conclusions:
- ING4 downregulation is associated with colorectal cancer progression.
- ING4 may play a significant role in the development and advancement of colorectal carcinoma.
- Further research into ING4's function could lead to novel diagnostic and therapeutic strategies.
Related Concept Videos
Inhibition of Cdk Activity
Experimental RNAi
